Why The Narrative Around Ginkgo Bioworks Holdings (DNA) Is Shifting After New Fair Value Reset [Yahoo! Finance]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Yahoo! Finance
This comes alongside a slightly higher discount rate and a lower revenue growth outlook, as analysts try to match expectations more closely with what they see as achievable, while still recognizing the value of clear multi year frameworks and multiple potential growth drivers. Stay tuned to see how you can keep on top of future price target moves and narrative shifts as they unfold. Stay updated as the Fair Value for Ginkgo Bioworks Holdings shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Ginkgo Bioworks Holdings. ?? Bullish Takeaways TD Cowen keeps a Buy rating on Ginkgo Bioworks, which signals that, in their view, the long term story around execution and growth prospects still has appeal even after resetting expectations. The firm highlights stocks with clear multi year frameworks and multiple avenues for upside to growth assumptions as most attractive, and Ginkgo Bioworks is included in this group, ty
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- Ginkgo Bioworks Holdings, Inc. (DNA) Increases Despite Market Slip: Here's What You Need to Know [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare ConferencePR Newswire
- Ginkgo Bioworks (NYSE:DNA) had its price target lowered by analysts at TD Cowen from $14.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- Ginkgo Bioworks Holdings, Inc. (DNA) Rises As Market Takes a Dip: Key Facts [Yahoo! Finance]Yahoo! Finance
DNA
Earnings
- 11/6/25 - Miss
DNA
Sec Filings
- 1/7/26 - Form 144
- 12/23/25 - Form 8-K
- 12/16/25 - Form 4
- DNA's page on the SEC website